Eplus Inc: Form 10-Q for the period ended Dec 31, 2020
Filed with the SEC on Feb 4, 2021 and accepted by EDGAR at Feb 3, 2021, 17:39 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-10-01 to 2020-12-31 | $427.6m | us-gaap:Revenues |
| Revenue | 9 months2020-04-01 to 2020-12-31 | $1.22bn | us-gaap:Revenues |
| Cost of revenue | 3 months2020-10-01 to 2020-12-31 | $329.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-04-01 to 2020-12-31 | $920.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-10-01 to 2020-12-31 | $98.2m | us-gaap:GrossProfit |
| Gross profit | 9 months2020-04-01 to 2020-12-31 | $295.7m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2020-10-01 to 2020-12-31 | $65.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-04-01 to 2020-12-31 | $201.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-10-01 to 2020-12-31 | $29.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-04-01 to 2020-12-31 | $82.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-10-01 to 2020-12-31 | $355.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2020-04-01 to 2020-12-31 | $1.2m | us-gaap:InterestExpense |
| Income tax | 3 months2020-10-01 to 2020-12-31 | $8.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-04-01 to 2020-12-31 | $25.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-10-01 to 2020-12-31 | $21.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-04-01 to 2020-12-31 | $58.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-10-01 to 2020-12-31 | $1.62 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-04-01 to 2020-12-31 | $4.39 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-10-01 to 2020-12-31 | $1.62 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-04-01 to 2020-12-31 | $4.41 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-10-01 to 2020-12-31 | 13,378,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-04-01 to 2020-12-31 | 13,402,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-04-01 to 2020-12-31 | $5.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 9 months2020-04-01 to 2020-12-31 | $6.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-12-31 | $86.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $826.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $1.13bn | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $531.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $580.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-12-31 | $545.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001022408-21-000003. Last ingested by Listed: Nov 6, 2026, 17:13 ET. Listed shows no prices and gives no investment advice.